Hodgkin’s Lymphoma Symptoms
There are no screening tests or early detection tests to find Hodgkin's lymphoma early, however, there are several potential symptoms that could alert a person to the possible presence of Hodgkin's.
Keep in mind when considering the following list of symptoms that: Many are non-specific (they can mean many things other than Hodgkin's), and that some people do not show any symptoms.
*The best thing any person can do is bring any concerns they have immediately to their physician or health care professional.
Symptoms
Swollen lymph nodes
Cough
Nodal pain
Night sweats
Weight loss
Fatigue
Fever/Chills
Pruritus
B Symptoms
The last five Hodgkin’s lymphoma symptoms listed are considered 'B' symptoms in and tend to signify a less optimistic prognosis than when they are not present.
Sources
Lymphomainfo.net
American Cancer Society
National Cancer Institute
More Articles
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...